Skip to main content
OpenTrials
Completed

NCT Number: NCT00950690

Efficacy and Tolerability of Xalatan in Patients

Efficacy data was not collected or analyzed. This study did assess safety and tolerability of Xalatan.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Pfizer Investigational Site, Alexandria, Egypt

Loading trial locations.

About this study

  • Efficacy data not collected or analyzed
  • Safety and tolerability of Xalatan assessed NA

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with ocular hypertension at least 22mg Hg
  • Patient must be over 18 years old

Exclusion criteria

  • None listed in the protocol

Treatment and study plan

Xalatan 0.005% eye drops

Drug

ophthalmic solution dosed once daily for 3 months

Other names: latanoprost

Primary outcomes

  1. Intraocular Pressure

    Time frame: Screening, 10 days, 4 weeks and 12 weeks after beginning treatment

    Intraocular pressure was measured at each visit

  2. Humphrey Perimetry Visual Field

    Time frame: Visits 1 and 4

    Analysis of visual field deficits for abnormalities.

Sponsors and collaborators

Lead sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Industry

Registry information

Official study title

Observational Study Assessing The Efficacy And Tolerability Of Xalatan™ In Patients With Open Angle Glaucoma And /Or Ocular Hypertension.

Acronym: A6111128

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Aug 3, 2009
Registry last updated
Feb 25, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.